Substance
CARFILZOMIB
Global reference: every product and company linked to this substance.
- cas: 868540-17-4
- ncit: C52196
- pubchem_cid: 11556711
- rxnorm: 1302966
- unii: 72X6E3J5AR
carfilzomib [INN] · CARFILZOMIB [JAN] · CARFILZOMIB [USAN] · Carfilzomib [WHO-DD] · KITPROZY · KYPROLIS · NSC-758252 · PR-171
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| AMGEN INC. COMMON STOCK | KYPROLIS | Q2 2026 | $314.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (3)
- CARFILZOMIB · DR. REDDY'S LABORATORIES LTD COMMON STOCK
- KITPROZY · AMNEAL PHARMACEUTICALS INC. CLASS A COMMON STOCK
- KYPROLIS · AMGEN INC. COMMON STOCK